C100 AB (publ) (FRA:V06)

Germany flag Germany · Delayed Price · Currency is EUR
0.0026
-0.0004 (-13.33%)
Last updated: Jun 26, 2026, 3:25 PM CET
Market Cap1.18M +181.8%
Revenue (ttm)-7.00 -96.9%
Net Income-456.14K
EPS-0.00
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.0026
Previous Close0.0030
Day's Range0.0026 - 0.0026
52-Week Range0.0010 - 0.0160
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About C100 AB

C100 AB (publ) is public investment firm specializing in early stage, Growth stage and Emerging stage. The Firm prefers to invest in Technology and Life science Sector. The Firm Typically focuses on early-stage biotech platforms, emerging digital health technologies, transformative software solutions for the investments. C100 AB (publ) was found in 2016 and is based in Stockholm, Sweden. [Read more]

Industry Management Consulting Services
Founded 2016
Employees 1
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol V06

Financial Performance

In 2025, C100 AB's revenue was 207,000, a decrease of -96.88% compared to the previous year's 6.64 million. Losses were -3.19 million, -31.49% less than in 2024.

Financial numbers in SEK Financial Statements

News

C100 AB Quarterly report: Q1 2026

C100 AB has published its Q1 2026 quarterly earnings report on May 15, 2026.

6 weeks ago - Filings

C100 AB Quarterly report: Q4 2025

C100 AB has published its Q4 2025 quarterly earnings report on February 11, 2026.

4 months ago - Filings

C100 AB Annual report: Q4 2025

C100 AB has published its Q4 2025 annual report on February 11, 2026.

4 months ago - Filings

C100 AB Quarterly report: Q3 2025

C100 AB has published its Q3 2025 quarterly earnings report on October 15, 2025.

9 months ago - Filings

C100 AB Quarterly report: Q2 2025

C100 AB has published its Q2 2025 quarterly earnings report on August 27, 2025.

10 months ago - Filings